Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIP Infusion Effects on Headache and Hemodynamics
NCT03989817Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of vasoactive intestinal peptide (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoints: Change in cranial hemodynamic and Occurrence and change of headache. Started Jun 2019; status: completed.
02
Drugs
vasoactive intestinal peptide
Beyond the preview
Go deeper on NCT03989817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03989817.